Clinical Trial Update: Efficacy and Safety of DS8201 in Metastatic Breast Cancer's Treatment

View source ↗

Summary

An ongoing clinical trial is investigating the efficacy and safety of DS8201 (trastuzumab deruxtecan) in metastatic breast cancer, currently enrolling by invita…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Enhertu (trastuzumab deruxtecan)

Snippet

Sponsor: The First Hospital of Jilin University | Conditions: Breast Cancer Metastatic, Efficacy and Safety | Status: ENROLLING_BY_INVITATION